Document Detail


N-terminal Pro-Atrial Natriuretic Peptide Measurement in Plasma Suggests Covalent Modification.
MedLine Citation:
PMID:  21715695     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The N-terminal fragment of cardiac-derived pro-B-type natriuretic peptide is a glycosylated polypeptide. It is unknown whether N-terminal pro-atrial natriuretic peptide (proANP) fragments are also covalently modified. We therefore evaluated the clinical performance of 2 distinctly different proANP assays on clinical outcome. METHODS: We examined 474 elderly patients with symptoms of heart failure presenting in a primary healthcare setting. Samples were analyzed with an automated immunoluminometric midregion proANP (MR-proANP) assay and a new processing-independent assay (PIA) developed in our laboratory. The results were compared with Bland-Altman plots, and clinical performance was assessed by generating ROC curves for different clinical outcomes. RESULTS: Despite linear regression results indicating a good correlation (r = 0.85; P < 0.0001), the PIA measured considerably more proANP than the MR-proANP assay (mean difference, 663 pmol/L; SD, 478 pmol/L). In contrast, the clinical performances of the 2 assays [as assessed by the area under the ROC curve (AUC)] in detecting left ventricular dysfunction were similar [proANP PIA, 0.71 (95% CI, 0.63-0.79); MR-proANP assay, 0.74 (95% CI, 0.66-0.81); P = 0.32]. The prognostic ability to report cardiovascular mortality during a 10-year follow-up revealed AUC values of 0.66 (95% CI, 0.60-0.71) for the proANP PIA and 0.69 (95% CI, 0.63-0.74) for the MR-proANP assay (P = 0.08, for comparing the 2 assays). CONCLUSIONS: Our data suggest that N-terminal proANP fragments in patient plasma differ from the calibrator peptides used but that the difference does not affect ROC curves in an elderly cohort of patients with mild to moderate heart failure. We suggest that human N-terminal proANP fragments can be covalently modified.
Authors:
Ingrid Hunter; Urban Alehagen; Ulf Dahlström; Jens F Rehfeld; Dan L Crimmins; Jens P Goetze
Related Documents :
20816205 - Glycomics profiling of heparan sulfate structure and activity.
14973415 - Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
18854305 - Discovery and validation of novel peptide agonists for g-protein-coupled receptors.
24043855 - Mining the genome of arabidopsis thaliana as a basis for the identification of novel bi...
10766755 - Structural requirements for n-trimethylation of lysine 115 of calmodulin.
1689745 - Localization of an encephalitogenic epitope for the sjl mouse in the n-terminal region ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-29
Journal Detail:
Title:  Clinical chemistry     Volume:  -     ISSN:  1530-8561     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Small Animal Clinical Sciences, KULIFE, University of Copenhagen, Copenhagen, Denmark;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell ...
Next Document:  Exercise reduces appetite and traffics excess nutrients away from energetically efficient pathways o...